Achieve Life Sciences (NASDAQ:ACHV) posted its earnings results on Thursday. The biopharmaceutical company reported ($0.55) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.18), Fidelity Earnings reports.
NASDAQ ACHV traded up $0.87 on Friday, reaching $3.32. 11,076,881 shares of the company’s stock traded hands, compared to its average volume of 1,721,912. The company has a market capitalization of $16.33 million, a PE ratio of -0.15 and a beta of 2.75. Achieve Life Sciences has a fifty-two week low of $1.04 and a fifty-two week high of $14.60.
Separately, Zacks Investment Research upgraded shares of Achieve Life Sciences from a “hold” rating to a “buy” rating and set a $2.00 target price for the company in a research report on Thursday, November 15th.
COPYRIGHT VIOLATION NOTICE: “Achieve Life Sciences (ACHV) Posts Earnings Results, Misses Expectations By $0.18 EPS” was first reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://dakotafinancialnews.com/2019/03/15/achieve-life-sciences-achv-posts-earnings-results-misses-expectations-by-0-18-eps.html.
Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms.
Read More: What causes a recession?
Receive News & Ratings for Achieve Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achieve Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.